Point of Care Test (POCT) Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)

Table of Contents

1. Executive Summary

2. Introduction
2.1 In Vitro Diagnostics: An Overview
2.1.1 Introduction
2.1.2 In-Vitro Diagnostics by End Users
2.2 Point of Care Test (POCT): An Overview
2.2.1 Introduction
2.2.2 Point of Care Test Sites
2.2.3 Point of Care Test (POCT) Benefits
2.2.4 Point of Care Test by Product
2.3 Point of Care Test Segmentation
2.3.1 Point of Care Test by Technology
2.3.2 Point of Care Test by Prescription

3. Global Market Analysis
3.1 Global Point of Care Test Market: An Analysis
3.1.1 Global Point of Care Test (POCT) Market by Value
3.1.2 Global Point of Care Test (POCT) Market by Product
3.1.3 Global Point of Care Test (POCT) Market by Technology
3.1.4 Global Point of Care Test (POCT) Market by Prescription
3.1.5 Global Point of Care Test (POCT) Market by Region
3.1.6 Global Point of Care Test (POCT) Market by Disease
3.2 Global Point of Care Test Market: Product Analysis
3.2.1 Global Glucose Monitoring POCT Market by Value
3.2.2 Global Blood Gas Electrolyte and Metabolite (BGEM) POCT Market by Value
3.2.3 Global Cardiac Makers POCT Market by Value
3.2.4 Global Infectious Disease POCT Market by Value
3.2.5 Global Alcohol & Drug Abuse POCT Market by Value
3.2.6 Global Pregnancy & Fertility POCT Market by Value
3.2.7 Global Hemoglobin POCT Market by Value
3.2.8 Global Cholesterol POCT Market by Value
3.2.9 Global Tumor Markers POCT Market by Value
3.2.10 Global Urine Chemistry POCT Market by Value
3.3 Global Point of Care Test Market: Technology Analysis
3.3.1 Global Biosensor POCT Market by Value
3.3.2 Global Microfluidics POCT Market by Value
3.4 Global Point of Care Test Market: Prescription Analysis
3.4.1 Global Over the Counter POCT Market by Value
3.4.2 Global Prescription-Based POCT Market by Value

4. Regional Market Analysis
4.1 North America Point of Care Test Market: An Analysis
4.1.1 North America Point of Care Test Market by Value
4.1.2 North America Point of Care Test Market by Country
4.1.3 The US Point of Care Test Market by Value
4.2 Asia Pacific Point of Care Test Market: An Analysis
4.2.1 Asia Pacific Point of Care Test Market by Value
4.2.2 Asia Pacific Point of Care Test Market by Country
4.2.3 Japan Point of Care Test Market by Value
4.2.4 China Point of Care Test Market by Value
4.3 Europe Point of Care Test Market: An Analysis
4.3.1 Europe Point of Care Test Market by Value

5. COVID-19
5.1 Impact of Covid-19 on Healthcare Industry
5.2 Impact of COVID-19 on Diagnostics Industry
5.3 Impact of COVID-19 on Point of Care Test

6. Market Dynamics
6.1 Growth Drivers
6.1.1 Growing Incidence of Infectious Diseases
6.1.2 Rising Aging Population
6.1.3 Expanding Healthcare Costs
6.1.4 Rising Number of Diabetics Patients
6.1.5 Cost Effectiveness
6.1.6 Rural Location with Limited Lab Services
6.2 Challenges
6.2.1 Difficulty in Management
6.2.2 Quality Concerns
6.2.3 Testing Performed by Non-Laboratory Personnel
6.2.4 Stringent Regulations
6.3 Market Trends
6.3.1 Advancement in Technology
6.3.2 Increase in Home-Based POC Usage
6.3.3 Decentralized Laboratory Testing
6.3.4 Healthcare Reform and Patient-Centered Care

7. Competitive Landscape
7.1 Global Point of Care Test Players’ Product Comparison
7.2 Global Infectious Disease POCT Market by Players

8. Company Profiles
8.1 Roche
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Business Strategy
8.2 Danaher Corporation
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Business Strategy
8.3 Abbott Laboratories
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Business Strategy
8.4 Siemens AG
8.4.1 Business Overview
8.4.2 Financial Overview
8.4.3 Business Strategy

List of Figures

Figure 1: In Vitro Diagnostics by End Users
Figure 2: Point of Care Test Sites
Figure 3: Point of Care Test (POCT) Benefits
Figure 4: Point of Care Test on the Basis of Product
Figure 5: Point of Care Test by Technology
Figure 6: Point of Care Test by Prescription
Figure 7: Global Point of Care Test Market by Value; 2015-2019 (US$ Billion)
Figure 8: Global Point of Care Test Market by Value; 2020-2024E (US$ Billion)
Figure 9: Global Point of Care Test Market by Product; 2019 (Percentage, %)
Figure 10: Global Point of Care Test Market by Technology; 2019 (Percentage, %)
Figure 11: Global Point of Care Test Market by Prescription; 2019 (Percentage, %)
Figure 12: Global Point of Care Test Market by Region; 2019 (Percentage, %)
Figure 13: Global Point of Care Test Market by Disease; 2018 (Percentage, %)
Figure 14: Global Glucose Monitoring POCT Market by Value; 2015-2019 (US$ Billion)
Figure 15: Global Glucose Monitoring POCT Market by Value; 2020-2024E (US$ Billion)
Figure 16: Global BGEM POCT Market by Value; 2015-2019 (US$ Billion)
Figure 17: Global BGEM POCT Market by Value; 2020-2024E (US$ Billion)
Figure 18: Global Cardiac Makers POCT Market by Value; 2015-2019 (US$ Billion)
Figure 19: Global Cardiac Makers POCT Market by Value; 2020-2024E (US$ Billion)
Figure 20: Global Infectious Disease POCT Market by Value; 2015-2019 (US$ Billion)
Figure 21: Global Infectious Disease POCT Market by Value; 2020-2024E (US$ Billion)
Figure 22: Global Alcohol & Drug Abuse POCT Market by Value; 2015-2019 (US$ Billion)
Figure 23: Global Alcohol & Drug Abuse POCT Market by Value; 2020-2024E (US$ Billion)
Figure 24: Global Pregnancy & Fertility POCT Market by Value; 2015-2019 (US$ Billion)
Figure 25: Global Pregnancy & Fertility POCT Market by Value; 2020-2024E (US$ Billion)
Figure 26: Global Hemoglobin POCT Market by Value; 2015-2019 (US$ Billion)
Figure 27: Global Hemoglobin POCT Market by Value; 2020-2024E (US$ Billion)
Figure 28: Global Cholesterol POCT Market by Value; 2015-2019 (US$ Million
Figure 29: Global Cholesterol POCT Market by Value; 2020-2024E (US$ Million)
Figure 30: Global Tumor Markers POCT Market by Value; 2015-2019 (US$ Million)
Figure 31: Global Tumor Markers POCT Market by Value; 2020-2024E (US$ Million)
Figure 32: Global Urine chemistry POCT Market by Value; 2015-2019 (US$ Million)
Figure 33: Global Urine Chemistry POCT Market by Value; 2020-2024E (US$ Million)
Figure 34: Global Biosensor POCT Market by Value; 2015-2019 (US$ Million)
Figure 35: Global Biosensor POCT Market by Value; 2020-2024E (US$ Million)
Figure 36: Global Microfluidics POCT Market by Value; 2015-2019 (US$ Million)
Figure 37: Global Microfluidics POCT Market by Value; 2020-2024E (US$ Million)
Figure 38: Global Over the Counter POCT Market by Value; 2015-2019 (US$ Million)
Figure 39: Global Over the Counter POCT Market by Value; 2020-2024E (US$ Million)
Figure 40: Global Prescription-Based POCT Market by Value; 2015-2019 (US$ Million)
Figure 41: Global Prescription-Based POCT Market by Value; 2020-2024E (US$ Million)
Figure 42: North America Point of Care Test Market by Value; 2015-2019 (US$ Billion)
Figure 43: North America Point of Care Test Market by Value; 2020-2024E (US$ Billion)
Figure 44: North America Point of Care Test Market by Country; 2019 (Percentage, %)
Figure 45: The US Point of Care Test Market by Value; 2015-2019 (US$ Billion)
Figure 46: The US Point of Care Test Market by Value; 2020-2024E (US$ Billion)
Figure 47: Asia Pacific Point of Care Test Market by Value; 2015-2019 (US$ Billion)
Figure 48: Asia Pacific Point of Care Test Market by Value; 2020-2024E (US$ Billion)
Figure 49: Asia Pacific Point of Care Test Market by Country; 2019 (Percentage, %)
Figure 50: Japan Point of Care Test Market by Value; 2015-2019 (US$ Billion)
Figure 51: Japan Point of Care Test Market by Value; 2020-2024E (US$ Billion)
Figure 52: China Point of Care Test Market by Value; 2015-2019 (US$ Million)
Figure 53: China Point of Care Test Market by Value; 2020-2024E (US$ Million)
Figure 54: Europe Point of Care Test Market by Value; 2015-2019 (US$ Billion)
Figure 55: Europe Point of Care Test Market by Value; 2020-2024E (US$ Billion)
Figure 56: Global Number of COVID-19 Cases; 2020 (Millions)
Figure 57: Global Number of HIV Patients; 2000-2018 (Million)
Figure 58: Population Age 65 and Above (% of Total population)
Figure 59: The US Health Expenditure (% of GDP)
Figure 60: Global Diabetics Population; 2010-2030 (Million)
Figure 61: Global Infectious Disease POCT Market by Players; 2018
Figure 62: Roche Net Sales; 2015-2019 (US$ Billion)
Figure 63: Roche Net Sales by Segments; 2019 (Percentage, %)
Figure 64: Roche Net Sales by Geography; 2019 (Percentage, %)
Figure 65: Danaher Corporation Net Sales; 2015-2019 (US$ Billion)
Figure 66: Danaher Corporation Net Sales by Segments; 2019 (Percentage, %)
Figure 67: Danaher Corporation Net Sales by Geography; 2019 (Percentage, %)
Figure 68: Abbott Net Sales; 2015-2019 (US$ Billion)
Figure 69: Abbott Net Sales by Segments; 2019 (Percentage, %)
Figure 70: Abbott Net Sales by Geography; 2019 (Percentage, %)
Figure 71: Siemens AG Revenue; 2015-2019 (US$ Billion)
Figure 72: Siemens AG Revenue by Segments; 2019 (Percentage, %)
Figure 73: Siemens AG Revenue by Geography; 2019 (Percentage, %)

List of Tables

Table 1: Global Point of Care Test Players’ Product Comparison
Table 2: Roche Point-of-Care Products

Executive Summary

Point of care test (POCT) is a type of diagnosis where tests are performed at or near a patient and at the site where care or treatment is provided. It is generally performed outside of a laboratory setting. Such type of testing provides results within a short span of time and allows for faster therapeutic action. Some of the common examples of POCT devices are blood glucose monitors, thermometers, home pregnancy tests, and rapid strep tests. Point of care tests can be performed in all forms of settings such as emergency/critical settings and self-care settings. Such type of diagnosis is also known as beside testing, near-patient testing, mobile testing, remote testing etc.

Point of care testing on the basis of product can be broadly categorized into glucose monitoring, BGEM, cardiac markers, infectious disease, pregnancy and fertility, alcohol & drug abuse, haemoglobin, cholesterol, and urine chemistry. Furthermore, on the basis of technology point of care test are bifurcated into biosensors and microfluidics.

The global point of care test market has shown tremendous growth over the past few years and projections are made that the market would grow at a rapid pace over the forecasted period (2020-2024) as well. The aging population and rising prevalence of infectious & chronic diseases are the major factors contributing to the growth of the market. Moreover, rising diabetic population, expanding healthcare costs, the cost-effectiveness of point of care testing etc. would further augment market growth.

However, the market faces some challenges which are restraining the growth. Some of the major challenges faced by the industry are difficulty in the management of POC testing, quality concern issues associated with POCT devices, testing performed by non-laboratory personnel etc. Though, the market growth would be further supported by various market trends like advancement in technology, an increase in home-based POC usage, the advent of decentralized laboratory testing etc.

Companies Mentioned

• Abbott Laboratories
• Danaher Corporation
• Roche
• Siemens AG